123 related articles for article (PubMed ID: 20441053)
1. The effect of the PPAR-gamma agonist rosiglitazone on neuroblastoma SK-N-SH cells in a metastatic xenograft mouse model.
Krieger-Hinck N; Schumacher U; Müller A; Valentiner U
Oncol Res; 2010; 18(8):387-93. PubMed ID: 20441053
[TBL] [Abstract][Full Text] [Related]
2. In vivo effects of rosiglitazone in a human neuroblastoma xenograft.
Cellai I; Petrangolini G; Tortoreto M; Pratesi G; Luciani P; Deledda C; Benvenuti S; Ricordati C; Gelmini S; Ceni E; Galli A; Balzi M; Faraoni P; Serio M; Peri A
Br J Cancer; 2010 Feb; 102(4):685-92. PubMed ID: 20068562
[TBL] [Abstract][Full Text] [Related]
3. Ligands for the peroxisome proliferator-activated receptor-gamma have inhibitory effects on growth of human neuroblastoma cells in vitro.
Valentiner U; Carlsson M; Erttmann R; Hildebrandt H; Schumacher U
Toxicology; 2005 Sep; 213(1-2):157-68. PubMed ID: 16009482
[TBL] [Abstract][Full Text] [Related]
4. Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells.
Cellai I; Benvenuti S; Luciani P; Galli A; Ceni E; Simi L; Baglioni S; Muratori M; Ottanelli B; Serio M; Thiele CJ; Peri A
Br J Cancer; 2006 Oct; 95(7):879-88. PubMed ID: 16969347
[TBL] [Abstract][Full Text] [Related]
5. Primary chemoprevention of endometrial hyperplasia with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone in the PTEN heterozygote murine model.
Wu W; Celestino J; Milam MR; Schmeler KM; Broaddus RR; Ellenson LH; Lu KH
Int J Gynecol Cancer; 2008; 18(2):329-38. PubMed ID: 18334011
[TBL] [Abstract][Full Text] [Related]
6. The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis.
Jeon EJ; Lee SK; Park YS; Kim DH; Yum JH; Park CS
Otolaryngol Head Neck Surg; 2008 Jul; 139(1):124-30. PubMed ID: 18585574
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD44 is associated with a metastatic pattern of human neuroblastoma cells in a SCID mouse xenograft model.
Valentiner U; Valentiner FU; Schumacher U
Tumour Biol; 2008; 29(3):152-60. PubMed ID: 18612220
[TBL] [Abstract][Full Text] [Related]
8. Effects of PPARγ agonistrosiglitazone on human retinoblastoma cell in vitro and in vivo.
Cao X; He L; Li Y
Int J Clin Exp Pathol; 2015; 8(10):12549-56. PubMed ID: 26722443
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
Wu JS; Lin TN; Wu KK
J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
[TBL] [Abstract][Full Text] [Related]
10. No effect of the PPAR-gamma agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo.
Kreutzer J; Jeske I; Hofmann B; Blumcke I; Fahlbusch R; Buchfelder M; Buslei R
Clin Neuropathol; 2009; 28(6):430-9. PubMed ID: 19919817
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of proliferation and transforming growth factor beta3 protein expression by peroxisome proliferators-activated receptor gamma ligands in human uterine leiomyoma cells.
Zhang CH; Wen ZQ; Li JF; Li CZ; Shi M; Yang GW; Lan SM; Zhu Y; Wang F; Zhang YJ; Wang YY; Zhang H
Chin Med J (Engl); 2008 Jan; 121(2):166-71. PubMed ID: 18272045
[TBL] [Abstract][Full Text] [Related]
12. The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer.
Chen QY; Huang XB; Zhao YJ; Wang HG; Wang JB; Liu LC; Wang LQ; Zhong Q; Xie JW; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Huang CM
Theranostics; 2022; 12(4):1904-1920. PubMed ID: 35198079
[No Abstract] [Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone attenuates allergic inflammation and inhibits expression of galectin-3 in a mouse model of allergic rhinitis.
Han JL; Ding RY; Zhao L; Ren Z; Jiang XJ
J Int Med Res; 2008; 36(4):830-6. PubMed ID: 18652780
[TBL] [Abstract][Full Text] [Related]
15. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice.
Duan SZ; Ivashchenko CY; Russell MW; Milstone DS; Mortensen RM
Circ Res; 2005 Aug; 97(4):372-9. PubMed ID: 16051889
[TBL] [Abstract][Full Text] [Related]
17. Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects.
Yoshizumi T; Ohta T; Ninomiya I; Terada I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Yi S; Miwa K
Int J Oncol; 2004 Sep; 25(3):631-9. PubMed ID: 15289864
[TBL] [Abstract][Full Text] [Related]
18. Dual Outcomes of Rosiglitazone Treatment on Fatty Liver.
Gao M; Ma Y; Alsaggar M; Liu D
AAPS J; 2016 Jul; 18(4):1023-31. PubMed ID: 27125895
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor gamma synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells.
Sun WH; Chen GS; Ou XL; Yang Y; Luo C; Zhang Y; Shao Y; Xu HC; Xiao B; Xue YP; Zhou SM; Zhao QS; Ding GX
Cancer Lett; 2009 Mar; 275(2):247-55. PubMed ID: 19056168
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats.
Liu D; Zeng BX; Zhang SH; Wang YL; Zeng L; Geng ZL; Zhang SF
Crit Care Med; 2005 Oct; 33(10):2309-16. PubMed ID: 16215386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
